• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

EFSUMB 技术评论-2023 更新:用于量化肿瘤灌注的动态对比增强超声(DCE-CEUS)。

EFSUMB Technical Review - Update 2023: Dynamic Contrast-Enhanced Ultrasound (DCE-CEUS) for the Quantification of Tumor Perfusion.

机构信息

Department General Internal Medicine, Kliniken Hirslanden Beau Site, Salem und Permanence, Bern, Switzerland.

Zentrum der Inneren Medizin, Johann Wolfgang Goethe Universitätsklinik Frankfurt, Frankfurt, Germany.

出版信息

Ultraschall Med. 2024 Feb;45(1):36-46. doi: 10.1055/a-2157-2587. Epub 2023 Sep 25.

DOI:10.1055/a-2157-2587
PMID:37748503
Abstract

Dynamic contrast-enhanced ultrasound (DCE-US) is a technique to quantify tissue perfusion based on phase-specific enhancement after the injection of microbubble contrast agents for diagnostic ultrasound. The guidelines of the European Federation of Societies for Ultrasound in Medicine and Biology (EFSUMB) published in 2004 and updated in 2008, 2011, and 2020 focused on the use of contrast-enhanced ultrasound (CEUS), including essential technical requirements, training, investigational procedures and steps, guidance regarding image interpretation, established and recommended clinical indications, and safety considerations. However, the quantification of phase-specific enhancement patterns acquired with ultrasound contrast agents (UCAs) is not discussed here. The purpose of this EFSUMB Technical Review is to further establish a basis for the standardization of DCE-US focusing on treatment monitoring in oncology. It provides some recommendations and descriptions as to how to quantify dynamic ultrasound contrast enhancement, and technical explanations for the analysis of time-intensity curves (TICs). This update of the 2012 EFSUMB introduction to DCE-US includes clinical aspects for data collection, analysis, and interpretation that have emerged from recent studies. The current study not only aims to support future work in this research field but also to facilitate a transition to clinical routine use of DCE-US.

摘要

动态对比增强超声(DCE-US)是一种基于注射微泡对比剂后相位特异性增强来定量组织灌注的技术,用于诊断超声。欧洲超声医学和生物学联合会(EFSUMB)于 2004 年发布并于 2008 年、2011 年和 2020 年更新的指南,重点关注对比增强超声(CEUS)的使用,包括基本技术要求、培训、研究程序和步骤、图像解释指导、已确立和推荐的临床适应证以及安全性考虑。然而,这里没有讨论使用超声对比剂(UCAs)获得的相位特异性增强模式的定量。本 EFSUMB 技术评论的目的是进一步为 DCE-US 的标准化建立基础,重点关注肿瘤治疗监测。它提供了一些关于如何量化动态超声对比增强的建议和描述,以及分析时间强度曲线(TICs)的技术解释。本研究不仅旨在支持该研究领域的未来工作,还旨在促进 DCE-US 向临床常规应用的转变。

相似文献

1
EFSUMB Technical Review - Update 2023: Dynamic Contrast-Enhanced Ultrasound (DCE-CEUS) for the Quantification of Tumor Perfusion.EFSUMB 技术评论-2023 更新:用于量化肿瘤灌注的动态对比增强超声(DCE-CEUS)。
Ultraschall Med. 2024 Feb;45(1):36-46. doi: 10.1055/a-2157-2587. Epub 2023 Sep 25.
2
An EFSUMB introduction into Dynamic Contrast-Enhanced Ultrasound (DCE-US) for quantification of tumour perfusion.EFSUMB 对动态对比增强超声(DCE-US)在肿瘤灌注量化中的应用介绍。
Ultraschall Med. 2012 Aug;33(4):344-51. doi: 10.1055/s-0032-1313026. Epub 2012 Jul 27.
3
EFSUMB guidelines 2011: comment on emergent indications and visions.EFSUMB 指南 2011:紧急适应证和愿景的评论。
Ultraschall Med. 2012 Jul;33 Suppl 1:S39-47. doi: 10.1055/s-0032-1312895. Epub 2012 Jun 21.
4
European Federation of Societies for Ultrasound in Medicine and Biology (EFSUMB): An Update on the Pediatric CEUS Registry on Behalf of the "EFSUMB Pediatric CEUS Registry Working Group".欧洲超声医学与生物学联合会(EFSUMB):代表“EFSUMB 儿科超声造影注册工作组”发布的儿科超声造影注册更新。
Ultraschall Med. 2021 Jun;42(3):270-277. doi: 10.1055/a-1345-3626. Epub 2021 Mar 9.
5
VueBox® perfusion analysis of dynamic contrast enhanced ultrasound provides added value in the diagnosis of small thyroid nodules.VueBox® 灌注分析在诊断甲状腺小结节中的应用
Clin Hemorheol Microcirc. 2023;83(4):409-420. doi: 10.3233/CH-221681.
6
Advantages and Limitations of Focal Liver Lesion Assessment with Ultrasound Contrast Agents: Comments on the European Federation of Societies for Ultrasound in Medicine and Biology (EFSUMB) Guidelines.超声造影剂评估肝脏局灶性病变的优势与局限性:对欧洲医学与生物学超声学会联合会(EFSUMB)指南的评论
Med Princ Pract. 2016;25(5):399-407. doi: 10.1159/000447670. Epub 2016 Jun 17.
7
Diagnostic Accuracy of CEUS LI-RADS for the Characterization of Liver Nodules 20 mm or Smaller in Patients at Risk for Hepatocellular Carcinoma.CEUS LI-RADS 在肝癌风险患者中对 20mm 或更小的肝脏结节的特征诊断准确性。
Radiology. 2020 Feb;294(2):329-339. doi: 10.1148/radiol.2019191086. Epub 2019 Dec 3.
8
EFSUMB guidelines 2011: comments and illustrations.EFSUMB 指南 2011:评论和说明。
Ultraschall Med. 2012 Jul;33 Suppl 1:S11-21. doi: 10.1055/s-0032-1312890. Epub 2012 Jun 21.
9
[Update on the use of contrast agents in ultrasonography: a review of the clinical guidelines of the European Federation of Societies for Ultrasound in Medicine and Biology (EFSUMB)].[超声检查中造影剂的应用更新:欧洲医学与生物学超声学会联合会(EFSUMB)临床指南综述]
Radiologia. 2009 Jul-Aug;51(4):362-75. doi: 10.1016/j.rx.2009.05.002. Epub 2009 Jul 2.
10
Guidelines and Good Clinical Practice Recommendations for Contrast-Enhanced Ultrasound (CEUS) in the Liver-Update 2020 WFUMB in Cooperation with EFSUMB, AFSUMB, AIUM, and FLAUS.肝脏对比增强超声(CEUS)临床实践指南及良好规范推荐-2020 年 WFUMB 与 EFSUMB、AFSUMB、AIUM 和 FLAUS 合作更新版。
Ultrasound Med Biol. 2020 Oct;46(10):2579-2604. doi: 10.1016/j.ultrasmedbio.2020.04.030. Epub 2020 Jul 24.

引用本文的文献

1
Contrast-Enhanced Harmonic Endoscopic Ultrasonography for Prediction of Aggressiveness and Treatment Response in Patients with Pancreatic Lesions.对比增强谐波内镜超声检查对胰腺病变患者侵袭性及治疗反应的预测作用
Cancers (Basel). 2025 Aug 1;17(15):2545. doi: 10.3390/cancers17152545.
2
Super-Resolution Contrast-Enhanced Ultrasound Examination Down to the Microvasculature Enables Quantitative Analysis of Liver Lesions: First Results.超分辨率对比增强超声检查深入微血管可实现肝脏病变的定量分析:初步结果
Life (Basel). 2025 Jun 20;15(7):991. doi: 10.3390/life15070991.
3
Qualitative and Quantitative Analysis of Contrast-Enhanced Ultrasound in the Characterization of Kidney Cancer Subtypes.
超声造影在肾癌亚型特征性诊断中的定性与定量分析
Diagnostics (Basel). 2025 Jul 16;15(14):1795. doi: 10.3390/diagnostics15141795.
4
How to Perform Cardiac Contrast-Enhanced Ultrasound (cCEUS): Part I.如何进行心脏对比增强超声检查(cCEUS):第一部分。
Diagnostics (Basel). 2025 Jul 9;15(14):1743. doi: 10.3390/diagnostics15141743.
5
The safety of combining Endostar with concurrent chemoradiotherapy for the treatment of locally advanced cervical cancer and the evaluation of its anti-angiogenic effects via transrectal contrast-enhanced ultrasound.恩度联合同步放化疗治疗局部晚期宫颈癌的安全性及经直肠超声造影评估其抗血管生成作用
Front Oncol. 2025 May 8;15:1514425. doi: 10.3389/fonc.2025.1514425. eCollection 2025.
6
Deep Learning for Classification of Solid Renal Parenchymal Tumors Using Contrast-Enhanced Ultrasound.基于对比增强超声的深度学习用于实性肾实质肿瘤分类
J Imaging Inform Med. 2025 May 6. doi: 10.1007/s10278-025-01525-3.
7
Demonstration of Hepatic Vein Abnormalities Using Contrast-Enhanced Sonography in Liver Diseases.利用超声造影在肝脏疾病中显示肝静脉异常
Diagnostics (Basel). 2025 Mar 12;15(6):709. doi: 10.3390/diagnostics15060709.
8
Mapping of prostate cancer microvascular patterns using super-resolution ultrasound imaging.使用超分辨率超声成像绘制前列腺癌微血管模式
Eur Radiol Exp. 2025 Feb 20;9(1):25. doi: 10.1186/s41747-025-00561-6.
9
Challenges in Diagnosing Focal Liver Lesions Using Contrast-Enhanced Ultrasound.使用超声造影诊断肝脏局灶性病变的挑战
Diagnostics (Basel). 2024 Dec 28;15(1):46. doi: 10.3390/diagnostics15010046.
10
[Imaging in chronic inflammatory bowel disease].[慢性炎症性肠病的影像学检查]
Inn Med (Heidelb). 2025 Jan;66(1):40-54. doi: 10.1007/s00108-024-01831-y. Epub 2024 Dec 20.